The results show that the tumor weight in the VEGFC-OE group was substantially greater than that in the control group and that, in the VEGFC-OE+DC101 group (0.18 ± 0.02 g versus 0.36 ± 0.01 g versus 0.28 ± 0.02 g) (Figure 5B), the tumor volume was substantially greater than that in the control group and the VEGFC-OE+DC101 group (Figure 5C). The gene discussed is VEGFC; the disease is neoplasm.